Aptevo Therapeutics Inc. (APVO)
NASDAQ · Healthcare
Aptevo Therapeutics Inc. Total Liabilities 2015–2022
Aptevo Therapeutics Inc. annual total liabilities history from 2015 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Aptevo Therapeutics Inc. total liabilities as of December 31, 2022: 16.2M, a 70.68% decrease year-over-year.
- Aptevo Therapeutics Inc. total liabilities for 2022 were 16.2M, a 70.68% decrease from 2021.
- Aptevo Therapeutics Inc. total liabilities for 2021 were 55.4M, a 49.88% increase from 2020.
- Aptevo Therapeutics Inc. total liabilities for 2020 were 37.0M, a 11.10% decrease from 2019.
- Aptevo Therapeutics Inc. total liabilities for 2019 were 41.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aptevo Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2022 | $16 |
| 2021 | $55 |
| 2020 | $37 |
| 2019 | $42 |
| 2018 | $37 |
| 2017 | $35 |
| 2016 | $41 |
| 2015 | $39 |
Aptevo Therapeutics Inc. Total Liabilities — FAQ
Aptevo Therapeutics Inc. (APVO) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see APVO's total liabilities history?
The chart and table above show Aptevo Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.